Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Provectus Biopharmaceuticals's total debt was $23.62K at Dec 31, 2025. For fiscal 2025 it was $23.62K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.62K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $23.62K | – |
| Q3 FY2025 | Sep 30, 2025 | $23.62K | – |
| Q3 FY2020 | Sep 30, 2020 | $39.06K | – |
| Q2 FY2020 | Jun 30, 2020 | $39.06K | – |
See a number that looks wrong?